Acelyrin Inc [SLRN] moved down -14.71: Why It’s Important

GBS Stock

Acelyrin Inc [NASDAQ: SLRN] price plunged by -14.71 percent to reach at -$0.7.

The one-year SLRN stock forecast points to a potential upside of 68.16. The average equity rating for SLRN stock is currently 1.67, trading closer to a bullish pattern in the stock market.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Guru’s Opinion on Acelyrin Inc [SLRN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for SLRN shares is $12.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on SLRN stock is a recommendation set at 1.67. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

H.C. Wainwright have made an estimate for Acelyrin Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on Aug-15-24. The new note on the price target was released on July 08, 2024, representing the official price target for Acelyrin Inc stock. Previously, the target price had yet another raise to $11, while Wells Fargo analysts kept a Equal Weight rating on SLRN stock.

The Average True Range (ATR) for Acelyrin Inc is set at 0.55 The Price to Book ratio for the last quarter was 0.71, with the Price to Cash per share for the same quarter was set at 6.41.

SLRN Stock Performance Analysis:

Acelyrin Inc [SLRN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -17.81. With this latest performance, SLRN shares dropped by -42.49% in over the last four-week period, additionally sinking by -46.72% over the last 6 months – not to mention a drop of -83.79% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for SLRN stock in for the last two-week period is set at 31.66, with the RSI for the last a single of trading hit 24.15, and the three-weeks RSI is set at 36.85 for Acelyrin Inc [SLRN]. The present Moving Average for the last 50 days of trading for this stock 5.11, while it was recorded at 4.69 for the last single week of trading, and 6.44 for the last 200 days.

Insight into Acelyrin Inc Fundamentals:

Acelyrin Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.86 and a Current Ratio set at 7.86.

Acelyrin Inc [SLRN] Institutonal Ownership Details

The top three institutional holders of SLRN stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in SLRN stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in SLRN stock with ownership which is approximately 5.1238%.